Skip to main content
OpenTrials
Completed

NCT Number: NCT05563389

Statin Impact on Hepatic Decompensation

The study aims to evaluate the impact of statin on hepatic decompensation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Quality of Life

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Tanta University

Tanta, Egypt

About this study

Cirrhosis is the late stage of liver damage and possess two phases:. The shift from compensated to decompensated cirrhosis is characterized by the onset of complications) which are associated with substantial morbidity and negative Impact on quality of life (QOL)Cirrhosis and its complications have a substantial economic, social, and personal impact on affected patients, as well as their families and caregivers

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • cirrhosis adult both sex

Exclusion criteria

  • renal insufficiency

Treatment and study plan

Atorvastatin 20mg

Drug

active arm

Other names: atorvastatin

Placebo

Drug

placebo arm

Primary outcomes

  1. impact on decompensation

    Time frame: 6 months

    change in recurrence of cirrhosis related complications

Sponsors and collaborators

Lead sponsor

Tanta University

Other

Registry information

Official study title

the Impact of Statin on Cirrhotic Patients

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Oct 3, 2022
Registry last updated
Apr 3, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.